Rachel Metz, PA
Surgical · Gainesville, GANPI 1477104834
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,537 of the $3,819 with a category attached, or 66.4%. Arthrex accounts for 74.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $2,903 and has fallen 90.1% since, to $287 in 2025.
Across 33 payments — averaging $115.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Johnson & Johnson$168
- Medical Device Business Services, Inc.$137
- Teleflex LLC$107
- Bioventus LLC$102
- Amgen$91
- plus $361 from 10 others
What the payments were for
- Travel & lodging$39210%
- Food & beverage$89023%
- Education$2,53766%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $2,855 |
| Johnson & Johnson | 2 | $168 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Teleflex LLC | 2 | $107 |
| Bioventus LLC | 3 | $102 |
| Amgen | 1 | $91 |
| Ferring Pharmaceuticals Inc. | 4 | $89 |
| Heron Therapeutics, Inc. | 3 | $58 |
| Medtronic | 1 | $52 |
| Vertex | 1 | $38 |
| Convatec Inc. | 1 | $30 |
| Smith+Nephew | 1 | $26 |
| AbbVie | 1 | $21 |
| Vericel Corporation | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STRATAFIX$113
- ETHICON$113
- DERMABOND PRINEO$113
How this compares
$3,819 in reported general payments places this provider in the 85th percentile of 372 surgical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 26 | $14,236 |
| Celecoxib | 37 | $858 |
| Cefadroxil | 48 | $280 |
| Meloxicam | 128 | $261 |
| Ibuprofen | 30 | $169 |
| Mupirocin | 30 | $155 |
| Ondansetron Hcl | 48 | $140 |
| Methocarbamol | 34 | $133 |
| Cyclobenzaprine Hcl | 15 | $94 |
| Methylprednisolone | 18 | $75 |
Paid to pharmacies, not to this prescriber.
Other surgical in Gainesville
- Samantha NewmanGainesville$8K
- Sean PerryGainesville$7K
- Austin MalcomGainesville$6K
- Allison HeddenGainesville$5K
- Lacey RovinelliGainesville$4K
- Lauren EdekerAlpharetta$305K
- Michael BerkeAtlanta$242K
- Emily WatsonAtlanta$150K
- Beretta Craft-CoffmanCanton$30K
- Sarah NayebosadriDuluth$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.